Our "premier specialist" intellectual property practice has been highlighted by the Legal Business – Legal 500 team, in an analysis of the top-tier firms in brand management, IP, and patent litigation UK firms.
The article mentions our involvement in the landmark vaccine manufacturing and distribution deal where we acted for Oxford University; and explains the advantages of the firm's independence from any structured international network: "being able to pick up the phone to whomever is the doing the leading work in another jurisdiction" instead of being constrained to liaise with less experienced colleagues from a partner firm or one's own foreign offices.
The article also describes how the complex patent litigation landscape has driven our leading patent litigation team to focus on jurisdictional challenges ("the new black to us" as Myles Jelf says).
We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.